Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

2025 AGM Results Statement

2 Dec 2025 16:44

RNS Number : 9471J
JPEL Private Equity Limited
02 December 2025
 

JPEL Private Equity Limited

Fourth Floor

Plaza House

Admiral Park, St Peter Port

Guernsey, GY1 4BF

www.jpelonline.com

 

 

JPEL ANNOUNCES RESULTS OF AGM

AND BOARD SUCCESSION

 

 

* * *

 

GUERNSEY, 2 DECEMBER 2025

 

JPEL Private Equity Limited (the "Company") announces that at the Annual General Meeting ("AGM") of the Company held on 2 December 2025, all resolutions put to shareholders at the AGM were duly passed.

 

SUMMARY OF RESOLUTIONS PROPOSED AT AGM

 

 

Special Resolutions

1. To renew the Company's authority to make purchases of up to 15 per cent. of its own issued US$ Equity Shares pursuant to any proposed Tender Offer.

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of the US$ Equity Shares.

 

Ordinary Resolutions

3. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2025.

4. To re-elect PricewaterhouseCoopers CI LLP as Auditors to the Company.

5. To re-authorise the Directors to determine the Auditors' remuneration.

6. To re-authorise and agree the remuneration of the Directors in accordance with the Articles of Incorporation.

7. To re-elect Trina Le Noury as a non-executive, independent director of the Company.

8. To re-elect Anthony (Tony) Dalwood as a non-executive, independent director of the Company.

 

 

 

Below, please find a summary of all votes received for JPEL's AGM: 

 

In Favour

Discretion

Against

Withheld

Resolution

Votes

%

Items

Votes

%

Items

Votes

%

Items

Votes

Items

1

15,561,578

100

14

0

0

0

0

0

0

496,448

1

2

15,561,578

100

14

0

0

0

0

0

0

496,448

1

3

15,561,578

100

14

0

0

0

0

0

0

496,448

1

4

15,561,578

100

14

0

0

0

0

0

0

496,448

1

5

15,561,578

100

14

0

0

0

0

0

0

496,448

1

6

15,561,578

100

14

0

0

0

0

0

0

496,448

1

7

15,335,078 

98.54

13

0

0

0

226,500

1.46

1

496,448

1

8

12,233,887 

78.62

12

0

0

0

3,327,691

21.38

2

496,448

1

 

NB: Percentage of Votes cast excludes Withheld votes and resolution 9 (relating to the re-election of Sean Hurst) was withdrawn from the meeting. The Board acknowledges that there was a significant minority vote (being in excess of 20 per cent) against resolution 8, and will duly engage with shareholders in relation to this matter.

 

* * *

 

 Board Succession

In light of two of the three Board directors having served for at least nine years a process is underway to refresh its configuration. In order to ensure an orderly Board succession plan, this process is anticipated to be completed within six months. The Board remains mindful of its fiduciary duties to all shareholders including its commitment to focus on minimising costs appropriately. 

 

As a first stage of this orderly transition, Sean Hurst had notified the Company of his intention to step-down from his position prior to the AGM with immediate effect. The Board and Manager would like to thank Sean for his valuable contribution during his time as Chair and wish him all the best in his future endeavours.

 

Tony Dalwood has been appointed Chair with immediate effect to oversee the succession plan. Trina Le Noury remains Chair of the Audit committee.

 

The appointment of additional Non-Executive Directors is progressed and, subject to completion of the relevant regulatory approvals, at least one new Director will join the Board shortly. A further update will be provided in due course.

 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQLLFBELLZFBX
Date   Source Headline
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company
15th Nov 201710:11 amRNSRetirement of 2017 ZDP Shares
9th Nov 20177:00 amRNS2017 AGM CIRCULAR
27th Oct 20174:33 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNet Asset Value(s) - September 2017
17th Oct 20179:40 amRNSDirector Declaration
13th Oct 20177:00 amRNSTiming of Retirement of 2017 ZDP Shares
11th Oct 20177:00 amRNSBerkshire Partners Acquires Accela
28th Sep 20177:00 amRNSAnnual Financial Report
27th Sep 20179:45 amRNSDirector Update
26th Sep 201711:11 amRNSNet Asset Value(s) - August 2017
7th Sep 20177:00 amRNSNet Asset Value(s) - July 2017
21st Aug 20172:21 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSNet Asset Value(s) - June 2017
5th Jul 20175:50 pmRNSNet Asset Value(s) - May 2017 Correction
30th Jun 20179:52 amRNSNet Asset Value(s) - May 2017
2nd Jun 20177:00 amRNSNet Asset Value(s) - April 2017
30th May 20174:34 pmRNSHolding(s) in Company
25th May 20174:42 pmRNSHolding(s) in Company
2nd May 20173:50 pmRNSNotice to Shareholders - Total Voting Rights
2nd May 20177:00 amRNSCompletion of Mandatory Redemption_ April 2017
24th Apr 20176:15 pmRNSNotification of Dealings in Shares
21st Apr 20177:00 amRNSQuarter End Review for March 2017
12th Apr 20177:00 amRNSMandatory Redemption_US$ Equity Shares_April 2017
11th Apr 20175:22 pmRNSNet Asset Value(s) - March 2017
7th Apr 20177:00 amRNSNet Asset Value(s) - February 2017
28th Mar 20174:56 pmRNSHalf-year Report
16th Mar 20176:04 pmRNSSale of Datamars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.